Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CIS-PLATINUM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 324 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cham, ST; Diakos, CI; Ellis, LT; Fenton, RR; Munk, VP; Messerle, BA; Hambley, TW
      Isomer formation in the binding of [PtCl2(cis-cyclohexane-1,3-diamine)] tooligonucleotides and the X-ray crystal structure of [PtCl2(cis-cyclohexane-1,3-diamine)]center dot dimethylformamide

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    2. Harrington, KJ
      Liposomal cancer chemotherapy: current clinical applications and future prospects

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Orlandi, A; Francesconi, A; Cocchia, D; Corsini, A; Spagnoli, LG
      Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro - Implications for the evolution of experimental intimal thickening

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. Laurie, SA; Pfister, DG; Kris, MG; Tong, WP; Chronowski, G; Pisters, KWM; Heelan, RT; Sirotnak, FM
      Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin

      CLINICAL CANCER RESEARCH
    5. Wang, MQ; Dake, MD; Wang, ZP; Cui, ZP; Gao, YA
      Isolated lower extremity chemotherapeutic infusion for treatment of osteosarcoma: Experimental study and preliminary clinical report

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    6. Shintani, S; Terakado, N; Alcalde, RE; Mihara, M; Nakahara, Y; Kiyoto, A; Yoshihama, Y; Ueyama, Y; Matsumura, T
      The influence of blood arterial oxygen condition on the tumor response to preoperative radiation therapy in oral cancer patients

      ONCOLOGY REPORTS
    7. Sileni, VC; Nortilli, R; Aversa, SML; Paccagnella, A; Medici, M; Corti, L; Favaretto, AG; Cetto, GL; Monfardini, S
      Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

      MELANOMA RESEARCH
    8. Westermann, AM; Grosen, EA; Katschinski, DM; Jager, D; Rietbroek, R; Schink, JC; Tiggelaar, CL; Jager, E; Vording, PZVS; Neuman, A; Knuth, A; Van Dijk, JDP; Wiedemann, GJ; Robins, HI
      Pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

      EUROPEAN JOURNAL OF CANCER
    9. Wagenaar, HC; Pecorelli, S; Mangioni, C; van der Burg, MEL; Rotmensz, N; Anastasopoulou, A; Zola, P; Veenhof, CHN; Lacave, AJ; Neijt, JP; van Oosterom, AT; Einhorn, N; Vermorken, JB
      Phase II study of mitomycin-C and cisplatin in disseminated, squamous cellcarcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

      EUROPEAN JOURNAL OF CANCER
    10. Erdlenbruch, B; Pekrun, A; Roth, C; Grunewald, RW; Kern, W; Lakomek, M
      Cisplatin nephrotoxicity in children after continuous 72-h and 3x1-h infusions

      PEDIATRIC NEPHROLOGY
    11. Moretti, S; Carli, P; Biggeri, A; Volpi, V; Pimpinelli, N
      Cohort study of metastatic melanoma patients in the Dermatology Institute of Florence 1990/1997

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    12. Vermorken, JB; Zanetta, G; Oliveira, CFD; van der Burg, MEL; Lacave, AJ; Teodorovic, I; Boes, GH; Colombo, N
      Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma ofthe uterine cervix: An EORTC Gynecological Cancer Cooperative Group study

      ANNALS OF ONCOLOGY
    13. Hara, K; Taguchi, M; Yagasaki, A
      Hydrolysis of platinum(II) phosphine complexes in aqueous 1.0 M NaNO3 medium

      POLYHEDRON
    14. Watanabe, K; Jinnouchi, K; Yagi, T
      Detection of single-stranded DNA (ssDNA) in the vestibule of guinea pigs after the application of cisplatinum (CDDP)

      ANTICANCER RESEARCH
    15. Cheng, PW; Kaga, K; Koyama, S; Kondo, K
      Temporal bone histopathology after treatment by a large amount of cisplatin: A case study

      OTOLARYNGOLOGY-HEAD AND NECK SURGERY
    16. Li, GM; Frenz, DA; Brahmblatt, S; Feghali, JG; Ruben, RJ; Berggren, D; Arezzo, J; Van de Water, TR
      Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy

      NEUROTOXICOLOGY
    17. Mundt, AJ; Rotmensch, J; Waggoner, SE; Yamada, D; Langhauser, C; Fleming, GF
      Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies

      GYNECOLOGIC ONCOLOGY
    18. Luce, RA; Hopkins, PB
      Chemical cross-linking of drugs to DNA

      DRUG-NUCLEIC ACID INTERACTIONS
    19. Feghali, JG; Liu, W; Van de Water, TR
      L-N-acetyl-cysteine protection against cisplatin-induced auditory neuronaland hair cell toxicity

      LARYNGOSCOPE
    20. Boudreaux, EA
      Molecular orbital studies relating to potential anticancer activity of cis-platinum ammines

      INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY
    21. Hatzopoulos, S; Di Stefano, M; Campbell, KCM; Falgione, D; Ricci, D; Rosignoli, M; Finesso, M; Albertin, A; Previati, M; Capitani, S; Martini, A
      Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions

      AUDIOLOGY
    22. Gradishar, WJ; Stephenson, P; Glover, DJ; Neuberg, DS; Moore, MR; Windschitl, HE; Piel, I; Abeloff, MD
      A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma - An Eastern Cooperative Oncology Group Study (E8188)

      CANCER
    23. Kim, NK; Kim, TY; Shin, SG; Park, YI; Lee, JA; Cho, YB; Kim, KH; Kim, DK; Heo, DS; Bang, YJ
      A phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies

      CANCER
    24. Chao, KC; Wang, PH; Chang, CC; Lai, CR; Ng, HT
      Establishment and characterization of a cell line, MT-213-VGH, isolated from a mixed mullerian tumor of the uterus

      ACTA CYTOLOGICA
    25. Harrington, KJ; Rowlinson-Busza, G; Syrigos, KN; Uster, PS; Vile, RG; Stewart, JSW
      Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery

      CLINICAL CANCER RESEARCH
    26. Nagata, Y; Araki, N; Kimura, H; Fujiwara, K; Okajima, K; Aoki, T; Mitsumori, M; Sasai, K; Hiraoka, M; Higuchi, T; Fujii, S
      Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    27. Vermorken, JB; Mangioni, C; Pecorelli, S; Van Der Burg, MEL; Van Oosterom, AT; Huinink, WWT; Rotmensz, N; Dalesio, O
      Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP)in disseminated squamous cell carcinoma of the uterine cervix

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    28. Hartmann, JT; Knop, S; Fels, LM; van Vangerow, A; Stolte, H; Kanz, L; Bokemeyer, C
      The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors

      ANTI-CANCER DRUGS
    29. Watanabe, K; Hess, A; Bloch, W; Michel, O
      Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin

      ANTI-CANCER DRUGS
    30. Hambley, TW; Ling, ECH; O'Mara, S; McKeage, MJ; Russell, PJ
      Increased targeting of adenine-rich sequences by (2-amino-2-methyl 3-butanone oxime)dichloroplatinum(II) and investigations into its low cytotoxicity

      JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    31. Mikola, M; Klika, KD; Arpalahti, J
      The kinetics of substitution reactions of mixed platinum(II)-bis(nucleoside) complexes in aqueous solution in the presence of thiourea; X-ray crystalstructure determination of cis-[Pt(NH3)(2)(adenosine-N7)(2)](ClO4)(2)center dot 3.5 H2O

      CHEMISTRY-A EUROPEAN JOURNAL
    32. Harrington, KJ; Lewanski, CR; Stewart, JSW
      Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development

      CLINICAL ONCOLOGY
    33. Kishimoto, S; Noguchi, T; Yamaoka, T; Fukushima, S; Takeuchi, Y
      In vitro release of SM-11355, cis[((1R,2R)-1,2-cyclohexanediamine-N,N ')bis(myristato)] platinum(II) suspended in lipiodol

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    34. Toyoda, H; Mizushima, T; Satoh, M; Iizuka, N; Nomoto, A; Chiba, H; Mita, M; Naganuma, A; Himeno, S; Imura, N
      HeLa cell transformants overproducing mouse metallothionein show in vivo resistance to cis-platinum in nude mice

      JAPANESE JOURNAL OF CANCER RESEARCH
    35. Somani, SM; Husain, K; Whitworth, C; Trammell, GL; Malafa, M; Rybak, LP
      Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: Antioxidant defense system

      PHARMACOLOGY & TOXICOLOGY
    36. Sener, G; Satiroglu, H; Kabasakal, L; Arbak, S; Oner, S; Ercan, F; Keyer-Uysal, M
      The protective effect of melatonin on cisplatin nephrotoxicity

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    37. Tassler, P; Dellon, AL; Lesser, GJ; Grossman, S
      Utility of decompressive surgery in the prophylaxis and treatment of cisplatin neuropathy in adult rats

      JOURNAL OF RECONSTRUCTIVE MICROSURGERY
    38. Chang, TC; Lai, CH; Hong, JH; Hsueh, S; Huang, KG; Chou, HH; Tseng, CJ; Tsai, CS; Chang, JT; Lin, CT; Chang, HH; Chao, PJ; Ng, KK; Tang, SGJ; Soong, YK
      Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer

      JOURNAL OF CLINICAL ONCOLOGY
    39. Weijl, NI; Rutten, MFJ; Zwinderman, AH; Keizer, HJ; Nooy, MA; Rosendaal, FR; Cleton, FJ; Osanto, S
      Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature

      JOURNAL OF CLINICAL ONCOLOGY
    40. Cardinaal, RM; de Groot, JCMJ; Huizing, EH; Veldman, JE; Smoorenburg, GF
      Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea

      HEARING RESEARCH
    41. du Bois, A
      Anthracyclines in ovarian cancer - Past, present and future

      ONKOLOGIE
    42. Fokkema, E; de Vries, EGE; Meijer, S; Groen, HJM
      Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    43. Zhang, JS; Imai, T; Otagiri, M
      Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin

      ARCHIVES OF TOXICOLOGY
    44. Bott-Kothari, T; Aron, BS; Bejarano, P
      Malignant thymoma with metastases to the gastrointestinal tract and ovary - A case report and literature review

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    45. Chen, L; Schechter, B; Arnon, R; Wilchek, M
      Tissue selective affinity targeting using the avidin-biotin system

      DRUG DEVELOPMENT RESEARCH
    46. Beer, T; Raghavan, D
      Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

      PROSTATE
    47. Schechter, B; Caldwell, G; Meirim, MG; Neuse, EW
      Preliminary toxicological studies of selected water-soluble polymer-platinum conjugates

      APPLIED ORGANOMETALLIC CHEMISTRY
    48. Sakamoto, M; Kaga, K; Kamio, T
      Extended high-frequency ototoxicity induced by the first administration ofcisplatin

      OTOLARYNGOLOGY-HEAD AND NECK SURGERY
    49. Hartmann, JT; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors

      INVESTIGATIONAL NEW DRUGS
    50. Ling, ECH; Allen, GW; Vickery, K; Hambley, TW
      The preparation, characterisation, and DNA adduct profile of 2-amino-2-methyl-3-butanoneoximedichloroplatinum(II), a platinum(II) complex designed tobind to GpA sequences of DNA

      JOURNAL OF INORGANIC BIOCHEMISTRY
    51. Dastychova, E; Semradova, V
      A case of contact hypersensitivity to platinum salts

      CONTACT DERMATITIS
    52. Thigpen, JT
      Chemotherapy for advanced ovarian cancer: Overview of randomized trials

      SEMINARS IN ONCOLOGY
    53. Zanetta, G; Fei, F; Mangioni, C
      Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: The experience of Monza

      SEMINARS IN ONCOLOGY
    54. Tandy, JR; Tandy, RD; Farris, P; Truelson, JM
      In vivo interaction of Cis-platinum and fosfomycin on squamous cell carcinoma

      LARYNGOSCOPE
    55. Urba, SG; Wolf, GT; Bradford, CR; Thornton, AF; Eisbruch, A; Terrell, JE; Carpenter, V; Miller, T; Tang, G; Strawderman, M
      Neoadjuvant therapy for organ preservation in head and neck cancer

      LARYNGOSCOPE
    56. Viale, M; Vannozzi, MO; Pastrone, I; Mariggio, MA; Zicca, A; Cadoni, A; Cafaggi, S; Tolino, G; Lunardi, G; Civalleri, D; Lindup, WE; Esposito, M
      Reduction of cisplatin nephrotoxicity by procainamide: Does the formation of a cisplatin-procainamide complex play a role?

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    57. DePriest, J; Zheng, GY; Goswami, N; Eichhorn, DM; Woods, C; Rillema, DP
      Structure, physical, and photophysical properties of platinum(II) complexes containing bidentate aromatic and bis(diphenylphosphino)methane as ligands

      INORGANIC CHEMISTRY
    58. O'Dwyer, PJ; Stevenson, JP; Johnson, SW
      Clinical pharmacokinetics and administration of established platinum drugs

      DRUGS
    59. Bompas, E; Freyer, G; Vitrey, D; Trillet-Lenoir, V
      Granulosa cell tumour: review of the literature

      BULLETIN DU CANCER
    60. Rixe, O
      Platinum compounds: mechanisms of action, mechanisms of cellular resistance in human cancers, interactions with ionising radiations, application to carboplatin

      BULLETIN DU CANCER
    61. Middleton, MR; Lorigan, P; Owen, J; Ashcroft, L; Lee, SM; Harper, P; Thatcher, N
      A randomized phase III study comparing decarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma

      BRITISH JOURNAL OF CANCER
    62. Okuda, M; Masaki, K; Fukatsu, S; Hashimoto, Y; Inui, K
      Role of apoptosis in cisplatin-induced toxicity in the renal epithelial cell line LLC-PK1 - Implication of the functions of apical membranes

      BIOCHEMICAL PHARMACOLOGY
    63. Kollmannsberger, C; Kuzcyk, M; Mayer, F; Hartmann, JT; Kanz, L; Bokemeyer, C
      Late toxicity following curative treatment of testicular cancer

      SEMINARS IN SURGICAL ONCOLOGY
    64. Tutt, ANJ; Lodge, N; Blake, PR
      Palliative chemotherapy in recurrent carcinoma of the cervix: an audit of the use of ifosfamide and review of the literature

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    65. Giles, FJ; O'Brien, SM; Santini, V; Gandhi, V; Plunkett, W; Seymour, JF; Robertson, LE; Kantarjian, HM; Keating, MJ
      Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: A phase II study

      LEUKEMIA & LYMPHOMA
    66. Orditura, M; De Vita, F; Roscigno, A; Infusino, S; Auriemma, A; Iodice, P; Ciaramella, F; Abbate, G; Catalano, G
      Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review)

      ONCOLOGY REPORTS
    67. Song, KM; Cowan, KH; Sinha, BK
      In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts

      ONCOLOGY RESEARCH
    68. Abdel-Gayoum, AA; El-Jenjan, KB; Ghwarsha, KA
      Hyperlipidaemia in cisplatin-induced nephrotic rats

      HUMAN & EXPERIMENTAL TOXICOLOGY
    69. Zhang, JG; Viale, M; Esposito, M; Lindup, WE
      Tiopronin protects against the nephrotoxicity of cisplatin in the rat

      HUMAN & EXPERIMENTAL TOXICOLOGY
    70. Pecorelli, S; Wagenaar, HC; Vergote, IB; Curran, D; Beex, LVA; Wiltshaw, E; Vermorken, JB
      Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC gynaecological cancer cooperative group study

      EUROPEAN JOURNAL OF CANCER
    71. Gianasi, E; Wasil, M; Evagorou, EG; Keddle, A; Wilson, G; Duncan, R
      HPMA copolymer platinates as novel antitumour agents: In vitro properties,pharmacokinetics and antitumour activity in vivo

      EUROPEAN JOURNAL OF CANCER
    72. Stark, T; Borkowski, G; Hildmann, A
      Ototoxicity of cisplatin in children.

      LARYNGO-RHINO-OTOLOGIE
    73. Petersen, PM; Hansen, SW
      The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer

      ANNALS OF ONCOLOGY
    74. Zanetta, G; Fei, F; Parma, G; Balestrino, M; Lissoni, A; Gabriele, A; Mangioni, C
      Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer

      ANNALS OF ONCOLOGY
    75. Lara, PN; Meyers, FJ
      Treatment options in androgen-independent prostate cancer

      CANCER INVESTIGATION
    76. Chapman, PB; Einhorn, LH; Meyers, ML; Saxman, S; Destro, AN; Panageas, KS; Begg, CB; Agarwala, SS; Schuchter, LM; Ernstoff, MS; Houghton, AN; Kirkwood, JM
      Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    77. Whitney, CW; Sause, W; Bundy, BN; Malfetano, JH; Hannigan, EV; Fowler, WC; Clarke-Pearson, DL; Liao, SY
      Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea asan adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study

      JOURNAL OF CLINICAL ONCOLOGY
    78. Campbell, KCM; Meech, RP; Rybak, LP; Hughes, LF
      D-Methionine protects against cisplatin damage to the stria vascularis

      HEARING RESEARCH
    79. Kamimura, T; Whitworth, CA; Rybak, LP
      Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in therat

      HEARING RESEARCH
    80. Okuda, M; Tsuda, K; Masaki, K; Hashimoto, Y; Inui, K
      Cisplatin-induced toxicity in LLC-PK1 kidney epithelial cells: role of basolateral membrane transport

      TOXICOLOGY LETTERS
    81. Kohno, N; Kitahara, S; Kawaida, M; Ohmuma, T
      Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    82. Lee, WL; Yuan, CC; Lai, CR; Wang, PH
      Hemoperitoneum is an initial presentation of recurrent granulosa cell tumors of the ovary

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    83. Sevillano, P; Habtemariam, A; Parsons, S; Castineiras, A; Garcia, ME; Sadler, PJ
      Gold(I)-induced chelate ring-opening of palladium(II) and platinum(II) triphos complexes

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    84. De Napoli, L; Iacovino, R; Messere, A; Montesarchio, D; Piccialli, G; Romanelli, A; Ruffo, F; Saviano, M
      Synthesis of platinum(II) complexes of thymidine and 1-methylthymine (1-MeThy); crystal structure of cis-[PtCl(1-MeThy)-(PPh3)(2)]

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    85. Castiglione, F; Dalla Mola, A; Porcile, G
      Protection of normal tissues from radiation and cytotoxic therapy: the development of amifostine

      TUMORI
    86. Nagata, Y; Okajima, K; Kokubo, M; Kanamori, S; Fujiwara, K; Mizowaki, T; Sasai, K; Hiraoka, M; Kataoka, N; Konishi, I
      Clinical results of transcatheter arterial infusion for uterine cervical cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    87. Perrin, LC; Cullinane, C; McFadyen, WD; Phillips, DR
      Sequence specificity and reactivity of the binding of phenazine-tethered platinum complexes to DNA

      ANTI-CANCER DRUG DESIGN
    88. Talarico, T; Phillips, DR; Deacon, GB; Rainone, S; Webster, LK
      Activity and DNA binding of new organoamidoplatinum (II) complexes

      INVESTIGATIONAL NEW DRUGS
    89. Bergstrom, P; Johnsson, A; Bergenheim, T; Henriksson, R
      Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat

      JOURNAL OF NEURO-ONCOLOGY
    90. Akaboshi, M; Kawai, K; Tanaka, Y; Takada, J; Fujii, N
      Cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules of HeLa cells treated with combinations of hyperthermia and cis-diamine(glycolato)platinum(II)

      BIOLOGICAL TRACE ELEMENT RESEARCH
    91. De Lauretis, A; De Capua, B; Barbieri, MT; Bellussi, L; Passali, D
      ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin

      SCANDINAVIAN AUDIOLOGY
    92. Dorr, RT; Holmes, BC
      Dosing considerations with amifostine: A review of the literature and clinical experience

      SEMINARS IN ONCOLOGY
    93. Walker, EM; Walker, SM
      Evolution of chemotherapy with platinum compounds

      ANNALS OF CLINICAL AND LABORATORY SCIENCE
    94. Wolf, JK; Mullen, J; Eifel, PJ; Burke, TW; Levenback, C; Gershenson, DM
      Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary

      GYNECOLOGIC ONCOLOGY
    95. Colombo, N; Parma, G; Franchi, D
      An active chemotherapy regimen for advanced ovarian sex cord stromal tumors

      GYNECOLOGIC ONCOLOGY
    96. Homesley, HD; Bundy, BN; Hurteau, JA; Roth, LM
      Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Groupstudy

      GYNECOLOGIC ONCOLOGY
    97. Mundt, AJ; Rotmensch, J; Waggoner, S; Quiet, C; Fleming, G
      Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies

      GYNECOLOGIC ONCOLOGY
    98. Kelly, KJ; Meehan, SM; Colvin, RB; Williams, WW; Bonventre, JV
      Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody

      KIDNEY INTERNATIONAL
    99. Hartmann, JT; Kollmannsberger, C; Kanz, L; Bokemeyer, C
      Platinum organ toxicity and possible prevention in patients with testicular cancer

      INTERNATIONAL JOURNAL OF CANCER
    100. Genedani, S; Bernardi, M; Bertolini, A
      Influence of antineoplastic drugs on morphine analgesia and on morphine tolerance

      EUROPEAN JOURNAL OF PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 03:04:58